CP-289,503
CP-289,503 is an inhibitor of the complement C5a receptor with an IC50 of 1 μM. C5a acts as an activator of leukocytes and phagocytes during complement system activation. The C5a receptor can bind to C5a, which can stimulate the upregulation of cell surface integrins and degranulation of inflammatory cells, leading to endothelial cell damage. C5a receptor inhibitors can block C5a signaling and inhibit a variety of inflammatory diseases[1].
Product Specifications
CAS Number
[1349637-14-4]
UNSPSC
12352005
Target
Complement System
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cp-289-503.html
Purity
98.21
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N(C1CCN(CC1)CCCC2=CC=C(C=C2)OC)CCC3=CC=C(C=C3)Cl)C4=CC=CC=C4
Molecular Formula
C30H35ClN2O2
Molecular Weight
491.06
References & Citations
[1]Blagg J, et al. Small, non-peptide C5a receptor antagonists: part 1. Bioorg Med Chem Lett. 2008 Oct 15;18 (20) :5601-4.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RAP1A (Ras-related Protein Rap-1A, C21KG, G-22K, GTP-binding Protein smg p21A, Ras-related Protein Krev-1, KREV1) (PE)
RAP1A (Ras-related Protein Rap-1A, C21KG, G-22K, GTP-binding Protein smg p21A, Ras-related Protein Krev-1, KREV1) (PE)